Alterations of Rb pathway (Rb-p16(INK4)-cyclin D1) in preinvasive bronchial lesions

Clinical Cancer Research

Volumn 5, Issue 2, 1999, Pages 243-250

  Brambilla, Elisabeth ^a,b,c   Gazzeri, Sylvie ^a   Moro, Denis ^a,b   Lantuejoul, Sylvie ^b   Veyrenc, Sylvie ^a   Brambilla, Christian ^a,b  

^a INSERM   (France)

^b HÔPITAL MICHALLON   (France)

^c Laboratoire de Pathologie Cellulaire   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P16;

ARTICLE; BRONCHUS CANCER; CANCER INVASION; DYSPLASIA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

BRONCHI; BRONCHIAL NEOPLASMS; CARCINOMA; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; RETINOBLASTOMA PROTEIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0033011732     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Roth, J. A. New approaches to treating early lung cancer. Cancer Res., 52 (Suppl.): 2652s-2657s, 1992.
2. Souhami, R. Lung cancer. Br. Med. J., 304: 1298-1301, 1992.
3. Gazdar, A. The molecular and cellular basis of human lung cancer. Anticancer Res., 13: 561-568, 1994.
4. Vogelstein, B., and Kinzler, K. W. The multistep nature of cancer. Trends Genet., 9: 138-141, 1993.
5. Auerbach, O., Hammond, E. C., and Garfinkel, I. Changes in bronchial epithelium in relation to cigarette smoking 1955-1960 vs 1970-1977. N. Engl. J. Med., 300: 381-386, 1979.
6. Lam, S., McAulay, C., Hung, J., LeRiche, J., Profio, A. E., and Palcic, B. Detection of dysplasia and carcinoma in situ with lung imaging fluorescence endoscope device. J. Thorac. Cardiovasc. Surg., 105: 1035-1040, 1993.
7. Hammond, W. G., Teplitz, R. L., and Benfield, J. R. Variable regression of experimental bronchial preneoplasia during carcinogenesis. J. Thorac. Cardiovasc. Surg., 101: 800-806, 1991.
8. Sawyer, R. W., Hammond, W. G., Teplitz, R. L., and Benfield, J. R. Regression of bronchial epithelial cancer in hamsters. Ann. Thorac. Surg., 56: 74-78, 1993.
9. Hung, J., Kishimoto, Y., Sugio, K., Virmani, A., McIntire, D. D., Minna, J. D., and Gazdar, A. F. Allele specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Am. Med. Assoc., 273: 558-563, 1995.
10. Kishimoto, Y., Sugio, K., Hung, J. Y., Virmani, A., McIntire, D. D., Minna, J. P., and Gazdar, A. F. Allele specific loss in chromosome 9p loci in preneoplastic lesions accompanying non small cell lung cancers. J. Natl. Cancer Inst. (Bethesda), 87: 1224-1229, 1995.
11. Mao, L., Lee, J. S., Kurie, J. M., Fan, Y. H., Lippman, S. M., Lee, J. J., Ro, J. Y., Broxson, A., Yu, R., Morice, R. C., Kemp, B. L., Khuri, F. R., Walsh, G. L., Hittelman, W. N., and Hong, W. K. Clonal genetic alterations in the lung of current and former smokers. J. Natl. Cancer Inst. (Bethesda), 89: 857-862, 1997.
12. Wistuba, I. I., Lam, S., Behrens, C., Virmani, A. K., Fong, K. M., LeRiche, J., Samet, J. M., Srivastava, S., Minna, J. D., and Gazdar, A. F. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst. (Bethesda), 89: 1366-1373, 1997.
13. Reissmann, P. T., Koga, H., Takahashi, R., Figlin, R. A., Holmes, E. C., Piantadosi, S., Cordon-Cardo, C., and Slamon, D. J. Inactivation of the retinoblastoma susceptibility gene in non small cell lung cancer. Oncogene, 8: 1913-1919, 1993.
14. INK4 expression in resected non-small cell lung tumors. Cancer Res., 56: 3415-3420, 1996.
15. Cairns, P., Mao, L., Merlo, A., Lee, D. J., Schwab, D., Eby, Y., Tokino, K., Van der Riet, P., Blaugrund, E., and Sidransky, D. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science (Washington DC), 265: 415-417, 1994.
16. Cairns, P., Polascik, P., Eby, T. J., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., and Westra, W. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat. Genet., 11: 210-212, 1995.
17. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 686-692, 1995.
18. Marchetti, A., Buttitta, F., Pellegrini, S., Bertacca, G., Chella, A., Caraicelli, V., Tognoni, V., Filardo, A., Angeletti, C. A., and Bevillacqua, G. Alterations of p16 (MTS1) in node positive non small cell lung carcinomas. J. Pathol., 181: 178-182, 1997.
19. INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res., 55: 1448-1451, 1995.
20. INK4A inactivation in non small cell lung cancers. Oncogene, 16: 497-505, 1998.
21. INK4 protein is restricted to the subset of lung cancer lines that retains wild type Rb. Oncogene, 9: 3375-3378, 1994.
22. INKA in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Res., 55: 6006-6011, 1995.
23. INK4 expression in resected non-small cell lung tumors. Cancer Res., 56: 3415-3420, 1996.
24. Sakaguchi, M., Fujii, Y., Hirabayashi, H., Yoon, N. E., Komoto, Y., One, T., Kusafuka, T., Okada, A., and Matsuda, H. Inversely correlated expression of p16 and Rb protein in non small cell lung cancers: an immunohistochemical study. Int. J. Cancer, 65: 442-445, 1996.
25. INK4 expression in primary lung cancers and cell lines. Cancer Res., 55: 505-509, 1995.
26. Kelley, M. J., Nakagawa, K., Steinberg, S. M., Mulshin, J. L., Kamb, A., and Johnson, B. E. Differential inactivation of CDKN2 and Rb protein in non small cell and small cell lung cancer cell lines. J. Natl. Cancer Inst. (Bethesda), 87: 756-760, 1995.
27. Yatabe, Y., Nakamura, S., Seto, M., Kuroda, H., Kagami, Y., Suzuki, R., Ogura, M., Kojima, M., Koshikawa, T., Veda, R., and Suchi, T. Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity. Am. J. Surg. Pathol., 20: 1110-1122, 1996.
28. Gillett, C., Fantl, V., Smith, R., Fisher, C., Bartek, J., Dickson, C., Barnes, D., and Peters, G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res., 54: 1812-1817, 1994.
29. Bartkova, J., Lukas, J., Strauss, M., and Bartek, J. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene, 10: 775-778, 1995.
30. Bellacosa, A., Almadori, G., Cavallo, S., Cadoni. G., Galli, J., Ferrandina, G., Scambia, G., and Neri, G. Cyclin D1 gene amplification in human laryngeal squamous cell carcinomas: prognostic significance and clinical implications. Clin. Cancer Res., 2: 175-180, 1996.
31. Sheyn, I., Noffsinger, A. E., Heffelfinger, S., Davis, B., Miller, M. A., and Fenoglio-Preiser, C. M. Amplification and expression of the cyclin D1 gene in anal and esophageal squamous cell carcinomas. Hum. Pathol., 28: 270-276, 1997.
32. Schauer, I. E., Siriwardana, S., Langan, T. A., and Sclafani, R. A. Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non small cell and small cell lung cancer. Proc. Natl. Acad. Sci. USA, 91: 7827-7831, 1994.
33. Mate, J. L., Ariza, A., Aracil, C., Lupez, D., Isamat, M., Perez-Piteira, J., and Navas-Palacias, J. J. Cyclin D1 overexpression in non small cell lung carcinoma: correlation with Ki67 labelling index and poor cytoplasmic differentiation. J. Pathol., 180: 395-399, 1995.
34. Alle, K. M., Henshall, S. M., Field, A. S., and Sutherland, R. L. Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast. Clin. Cancer Res., 4: 847-854, 1998.
35. Histological typing of lung tumours. In: International Histological Classification of Tumours, Ed. 2. Geneva: WHO, 1981.
36. Brambilla, E., Gazzeri, S., Lantuejoul, S., Coll, J. L, Moro, D., Negoescu. A., and Brambilla, C. p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bc12, Bax, Waf1) in precursor bronchial lesions of lung cancer. Clin. Cancer Res., 4: 1609-1618, 1998.
37. Brambilla, E., Moro, D., Veale, D., Brichon, P. Y., Stoebner, P., Paramelle, B., and Brambilla, C. Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognosis significance. Hum. Pathol., 23: 993-1003, 1992.
38. Travis, W. D., Linnoila, R. I., Tsokos, M. G., Hitchcock, C. L., Cutler, G. B., Nieman, L., Chrousos, G., Pass, H., and Doppan, J. Neuroendocrine tumors of the lung with proposed criteria for large cell neuroendocrine carcinoma: an ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am. J. Surg. Pathol., 15: 529-553, 1991.
39. Geradts, J., Hu, S. X., Lincoln, C. E., Benedict, W. F., and Xu, H. J. Aberrant Rb gene expression in routinely processed archival tumor tissues determined by three different anti-Rb antibodies. Int. J. Cancer, 58: 161-167, 1994.
40. Sherr, C. J. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
41. Chen, W., Bargonette, J., and Prives, C. p53 through p21 (Waf1/ Cip1), induces cycun D1 synthesis. Cancer Res., 55; 4257-4263, 1995.
42. Kotelnikov, V. M., Coon, J. S., Mundle, S., Kelanic, S., La Follette, S., Taylor, S., Hutchinson, J., Panje, W., Caldarelli, D., and Preiser, H. D. Cyclin D1 expression in squamous cell carcinomas of the head and neck and in oral mucosa in relation to proliferation and apoptosis. Clin. Cancer Res., 3: 95-101, 1997.
43. Berenson, J. R., Koga, J., Yang, J., Pearl, J., Holmes, E. C., and Figlin, R. Frequent amplification of the bel-1 locus in poorly differential squamous cell carcinoma of the lung. Oncogene. 5: 1343-1348, 1990.